Bradley M. Fluegel's most recent trade in Performant Financial Corp was a trade of 36,011 Restricted Stock Units done . Disclosure was reported to the exchange on July 30, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Performant Financial Corp | Bradley M. Fluegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2024 | 36,011 | 36,011 | - | - | Restricted Stock Units | |
| Neurometrix Inc. | Bradley M. Fluegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 13,730 | 13,730 | - | - | Restricted Stock Unit | |
| American Oncology Network ... | Bradley M. Fluegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2024 | 14,981 | 39,981 | - | 0 | Class A Common Stock | |
| Neurometrix Inc. | Bradley M. Fluegel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2024 | 5,396 | 0 | - | - | Restricted Stock Unit | |
| Neurometrix Inc. | Bradley M. Fluegel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.37 per share. | 30 Apr 2024 | 5,396 | 8,634 (0%) | 0% | 4.4 | 23,581 | Common Stock |
| Performant Financial Corp | Fluegel M. Bradley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2024 | 27,675 | 27,675 | - | - | Restricted Stock Units | |
| Neurometrix Inc. | Bradley M. Fluegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2023 | 43,165 | 43,165 | - | - | Restricted Stock Unit | |
| Neurometrix Inc. | Bradley M. Fluegel | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.40 per share. | 30 Sep 2022 | 1,041 | 25,914 (1%) | 0% | 1.4 | 1,457 | Common Stock |
| Neurometrix Inc. | Bradley M. Fluegel | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.79 per share. | 30 Sep 2022 | 517 | 26,955 (1%) | 0% | 2.8 | 1,442 | Common Stock |
| Performant Financial Corp | Bradley M. Fluegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2022 | 35,377 | 35,377 | - | - | Restricted Stock Units | |
| Neurometrix Inc. | Bradley M. Fluegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 27,472 | 27,472 (1%) | 1% | 0 | Common Stock | |
| Performant Financial Corp | Bradley M. Fluegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2021 | 16,741 | 16,741 | - | - | Restricted Stock Units | |
| Performant Financial Corp | Bradley M. Fluegel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2020 | 117,206 | 117,206 | - | - | Restricted Stock Units |